PreprintAll rights reservedbioRxiv
Bispecific VSV-G Engagers: A Platform for Cell-Type-Specific Delivery of Viral Vectors
- 1Weizmann Institute of Science
Related
- Efficacy and specific toxicity profiles of GPRC5D- versus BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: a meta-analysis of clinical trials and real-world studies
- Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics
- CD3-CSPG4 bispecific T cell engager: A novel platform for malignant melanoma therapy
- Stealthy lentiviral vectors: Breaking the barriers to systemic in vivo gene delivery
- Nonviral, ultrasound-triggered gene delivery platform via gas-core cationic nanobubbles
BibTeX
@misc{nenavath2026bispecific,
title = {{Bispecific VSV-G Engagers: A Platform for Cell-Type-Specific Delivery of Viral Vectors}},
author = {G. N. Nenavath and D. Gataulin and M. Eisenstein and G. Schreiber and M. S. Hasan and N. Packiriswamy and P. Jain and T. Kadungure and H. Anantharama and C.-H. Chin and A. Kancharla and H. Salimi and P. Lech and L. Blancas-Mejia and M. Munoz-Alia and K.-W. Peng and S. Russell and M. Rubinstein},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.02.763599},
url = {https://www.biorxiv.org/content/10.64898/2026.11.02.763599v1},
}
RIS
TY - UNPB
TI - Bispecific VSV-G Engagers: A Platform for Cell-Type-Specific Delivery of Viral Vectors
AU - G. N. Nenavath
AU - D. Gataulin
AU - M. Eisenstein
AU - G. Schreiber
AU - M. S. Hasan
AU - N. Packiriswamy
AU - P. Jain
AU - T. Kadungure
AU - H. Anantharama
AU - C.-H. Chin
AU - A. Kancharla
AU - H. Salimi
AU - P. Lech
AU - L. Blancas-Mejia
AU - M. Munoz-Alia
AU - K.-W. Peng
AU - S. Russell
AU - M. Rubinstein
PY - 2026
DA - 2026/11/02
PB - bioRxiv
DO - 10.64898/2026.11.02.763599
UR - https://www.biorxiv.org/content/10.64898/2026.11.02.763599v1
ER -